Differential Display Identified Changes in mRNA Levels in Regenerating Livers from Chloroform-Treated Mice

Molecular Carcinogenesis

Volumn 20, Issue 3, 1997, Pages 288-297

  Kegelmeyer, Alma E ^a,b   Sprankle, Catherine S ^a   Horesovsky, Gregory J ^a,c   Butterworth, Byron E ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

B6C3F1; Carcinogenesis; Cytotoxic chemicals; Differential display; Gene expression; Mouse; Polymerase chain reaction

Indexed keywords

ANIMALIA; RODENTIA;

CARCINOGEN; CHLOROFORM; COMPLEMENTARY DNA; MESSENGER RNA;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; LIVER; LIVER DISEASE; LIVER REGENERATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; RAT; SEQUENCE HOMOLOGY;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOGENS; CHLOROFORM; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; LIVER; LIVER DISEASES; LIVER REGENERATION; MICE; MOLECULAR SEQUENCE DATA; RATS; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0031280116     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199711)20:3<288::AID-MC5>3.0.CO;2-H     Document Type: Article

References (32)

1. Symons JM, Bellar T, Carswell J, et al. National organics reconnaissance survey for halogenated organics. Journal of the American Water Works Association 67:634-647, 1975.
2. Lahl U, Batjer K, Duszeln JV, Gabel B, Stachel B, Thiemann W. Distribution and balance of volatile halogenated hydrocarbons in the water and air of covered swimming pools using chlorine for water disinfection. Water Research 15:803-814, 1981.
3. Deinzer M, Schaumburg F, Klein E. Environmental health sciences center task force review on halogenated organics in drinking water. Environ Health Perspect 24:209-239, 1978.
4. Leuenberger C, Giger W, Coney R, Craydon JW. Persistent chemicals in pulp mill effluents. Occurrence and behavior in an activated sludge treatment plant. Water Research 19:885-894, 1985.
5. Butterworth BE, Conolly RB, Morgan K. A strategy of establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett 93:129-146, 1995.
6. International Programme on Chemical Safety. Chloroform, Environmental Health Criteria 163, World Health Organization, Geneva, 1994.
7. Butterworth BE, Popp JA, Conolly RB, Goldsworthy TL. Chemically-induced cell proliferation in carcinogenesis. In: Vainio H, Magee PN, McGregor DB, McMichael AJ (eds), Mechanisms of Carcinogenesis in Risk Identification. International Agency for Research on Cancer, Lyon, 1992, pp. 279-305.
8. National Cancer Institute. Carcinogenesis Bioassay of Chloroform (National Tech. Inform. Service No. PB264018/AS). NCI, Bethesda, MD, 1976.
9. 1 mice: Comparison of administration by gavage in corn oil vs ad libitum in drinking water. Fundam Appl Toxicol 22:90-102, 1994.
10. 1 mice. Fundam Appl Toxicol 5:760-769, 1985.
11. 1 mice. Mol Carcinog 9:24-32, 1994.
12. Goldsworthy TL, Goldsworthy SM, Sprankle CS, Butterworth BE. Expression of myc, fos, and H-ras associated with chemically induced cell proliferation in the rat liver. Cell Prolif 27:269-278, 1994.
13. 1 1 mice and F-344 rats. Cell Prolif 27:529-539, 1994.
14. Sprankle CS, Larson JL, Goldsworthy SM, Butterworth BE. Levels of myc, fos, Ha-ras, met and hepatocyte growth factor mRNA during regenerative cell proliferation in female mouse liver and male rat kidney after a cytotoxic dose of chloroform. Cancer Lett 101:97-106, 1996.
15. Kahn P, Graf T. Oncogenes and Growth Control. Springer-Verlag, Berlin-Heidelberg, 1986.
16. Antoniades HN. Linking cellular injury to gene expression and human proliferative disorders: Examples with the PDGF genes. Mol Carcinog 6:175-181, 1992.
17. Bailey A, Saliba D, Miller DM. A marked increase in sensitivity to carcinogenesis is associated with induced protooncogene expression without DNA synthesis. Proceedings of the American Association for Cancer Research 30:183, 1989.
18. Stewart TA, Pattengale PK, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/ myc fusion genes. Cell 38:627-637, 1984.
19. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538, 1985.
20. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-970, 1992.
21. National Institutes of Health. Guide for the care and use of laboratory animals, U.S. Department of Health and Human Services, Public Health Service, NIH Publication, 1985.
22. Goldsworthy S, Goldsworthy T, Sprankle C, Butterworth B. Variation in expression of genes used for normalization of Northern blots after induction of cell proliferation. Cell Prolif 26:511-517, 1993.
23. Altschul S, Gish W, Miller W, Myers E, Lipman D. Basic local alignment search tool. J Mol Biol 215:403-410, 1990
24. Blok L, Kumar MV, Tindall DJ. Isolation of differentially expressed cDNAs between androgen-dependent and androgen-independent prostate carcinoma cell lines using differential display PCR. Prostate 26:213-224, 1995.
25. Adams MD, Dubnick M, Kerlavage AR, et al. Sequence identification of 2,375 human brain genes. Nature 355:632-634, 1992.
26. Bauer D, Muller H, Reich J, et al. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res 21:4272-4280, 1993.
27. Utans U, Liang P, Wyner LR, Karnovsky MJ, Russell ME. Chronic cardiac rejection: Identification of five upregulated genes in transplanted hearts by differential mRNA display. Proc Natl Acad Sci USA 91:6463-6467, 1994.
28. Zhang L, Medina D. Gene expression screening for specific genes associated with mouse mammary tumor development. Mol Carcinog 8:123-126, 1993.
29. Mou L, Miller H, Li J, Wang E, Chalifour L. Improvements to the differential display method for gene analysis. Biochem Biophys Res Commun 199:564-569, 1994.
30. Fletcher B, Lim R, Varnum B, Kujubu D, Koski R, Herschman H. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511-14518, 1991.
31. Lin W, Gary J, Yang M, Clarke S, Herschmann H. The mammalian immediate-early tis21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271:15034-15044, 1996.
32. Mesner P, Epting C, Hegarty J, Green S. A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J Neurosci 15:7357-7366, 1995.